Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination

Journal of Controlled Release : Official Journal of the Controlled Release Society
Yi-Nan ZhangWarren C W Chan

Abstract

30-99% of administered nanoparticles will accumulate and sequester in the liver after administration into the body. This results in reduced delivery to the targeted diseased tissue and potentially leads to increased toxicity at the hepatic cellular level. This review article focuses on the inter- and intra-cellular interaction between nanoparticles and hepatic cells, the elimination mechanism of nanoparticles through the hepatobiliary system, and current strategies to manipulate liver sequestration. The ability to solve the "nanoparticle-liver" interaction is critical to the clinical translation of nanotechnology for diagnosing and treating cancer, diabetes, cardiovascular disorders, and other diseases.

References

Jul 1, 1991·Biochimica Et Biophysica Acta·M NegishiA Ichikawa
Mar 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G RenaudR J Havel
Sep 14, 1994·Journal of Immunological Methods·N Van Rooijen, A Sanders
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·J A KampsG L Scherphof
Apr 22, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·K OgawaraM Hashida
Apr 27, 1999·FEBS Letters·E L RomeroG L Scherphof
Jun 8, 1999·Annual Review of Immunology·A Aderem, D M Underhill
Jun 6, 2000·Advanced Drug Delivery Reviews·Y TakakuraM Hashida
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·C A Janeway
Apr 12, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Praneet OpanasopitMitsuru Hashida
Mar 5, 2003·Journal of Cell Science·Bradley W Doble, James R Woodgett
Jul 2, 2003·Nature Biotechnology·Tadanori YamadaShun'ichi Kuroda
Jan 5, 2005·Toxicology and Applied Pharmacology·G Papanikolaou, K Pantopoulos
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Oct 18, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shao-Ning WangDa-Wei Chen
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vito Racanelli, Barbara Rehermann
Jun 6, 2006·Molecular Pharmaceutics·Giulia GhibelliniKim L R Brouwer
Jan 12, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dmitri SimbergErkki Ruoslahti
Feb 23, 2007·The Journal of Pharmacology and Experimental Therapeutics·Joanna E AdrianJan A A M Kamps
Apr 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Soo In KimMeehyein Kim
May 19, 2007·The Journal of Pharmacology and Experimental Therapeutics·Shi-Lin DuJi-Yao Wang
Sep 11, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Marie GaumetFlorence Delie
Sep 25, 2007·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Oct 30, 2007·Small·Yu PanWilli Jahnen-Dechent
Jan 26, 2008·Molecular Pharmaceutics·Tapan K JainVinod Labhasetwar
May 7, 2008·International Journal of Pharmaceutics·Aihua LinQineng Ping
May 17, 2008·Nuclear Medicine and Biology·Stephen J KennelSaed Mirzadeh
May 23, 2008·Toxicology and Applied Pharmacology·Zhen ChenXiaohong Fang
Jun 13, 2008·Pharmaceutical Research·Julie A Champion, Samir Mitragotri
Jul 26, 2008·Nature Nanotechnology·Yan GengDennis E Discher
Jul 26, 2008·Nature Nanotechnology·Marina A Dobrovolskaia, Scott E McNeil
Nov 26, 2008·Small·Manuela Semmler-BehnkeWolfgang Brandau

❮ Previous
Next ❯

Citations

Jun 18, 2016·International Journal of Molecular Sciences·Shahnaz Bakand, Amanda Hayes
Feb 23, 2017·Drug Delivery·Ahmed AlalaiweStephen Roberts
Mar 23, 2017·ACS Applied Materials & Interfaces·Anqi SunXiangang Hu
Feb 23, 2018·Advanced Materials·Kevin J McHughAna Jaklenec
Feb 2, 2018·Advanced Materials·Joël BourquinBarbara Rothen-Rutishauser
Aug 8, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Bin Li, Lucas A Lane
Aug 10, 2018·Journal of Applied Toxicology : JAT·Jie LuTing Zhang
Jun 21, 2018·Advanced Healthcare Materials·Cristina FornagueraSalvador Borrós
Jun 20, 2018·Archives of Environmental & Occupational Health·Amara SalemMohsen Sakly
Mar 23, 2019·Expert Opinion on Drug Delivery·Rafael R CastilloMaría Vallet-Regí
Oct 1, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Usman ArshadAndrew Owen
Nov 9, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Juan L Vivero-EscotoJennifer H Benbow
Aug 20, 2019·Current Pharmaceutical Design·Julio Cezar de Almeida JuniorRalph Santos-Oliveira
Mar 17, 2020·Chemical Society Reviews·Xueli ZhaoXiaoyuan Chen
Sep 29, 2019·Advanced Materials·Meilyn SylvestreSuzie H Pun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

Seminars in Surgical Oncology
L H Blumgart, Y Fong
Cancer Control : Journal of the Moffitt Cancer Center
J N Vauthey
Ultrasound in Medicine & Biology
K J Taylor
© 2022 Meta ULC. All rights reserved